Tumor‑type‑dependent effects on the angiogenic abilities of endothelial cells in an in vitro rat cell model.


Journal

Oncology reports
ISSN: 1791-2431
Titre abrégé: Oncol Rep
Pays: Greece
ID NLM: 9422756

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 04 10 2018
accepted: 11 04 2019
pubmed: 7 5 2019
medline: 24 12 2019
entrez: 7 5 2019
Statut: ppublish

Résumé

Adequate vascularization is pivotal for tumor progression and metastasis. Tumor angiogenesis is based on a sequence of interactions between the tumor and surrounding cells and the extracellular matrix. It is widely known that a tumor can influence and control its surroundings to create favorable conditions for further growth. To investigate the influence of various tumor types on endothelial cells (ECs), an in vitro rat cell model was used and rat liver EC52 cells were co‑cultured with conditioned medium derived from breast cancer MCR86, osteosarcoma ROS‑1, colon cancer CC531 and rhabdomyosarcoma R1H cell lines. In a distinct tumor‑type‑dependent manner, the EC52 cells exhibited changes in their function and gene expression. In all functional cell culture assays (proliferation, migration, transmigration, invasion and tube formation) the breast cancer cells exerted a significant effect on the angiogenic abilities of the ECs. When comparing the various tumor cell types, only the breast and colon cancer cells led to a significant stimulation of the EC migration and invasion. Proliferation, migration, invasion and tube formation were not or only hardly influenced by the osteosarcoma or rhabdomyosarcoma cells. Similarly, the breast and colon cancer cells exhibited the strongest influence on the upregulation of EC angiogenic genes, including the ones encoding vascular endothelial growth factor A, platelet and endothelial cell adhesion molecule 1, fibroblast growth factor 2, Von Willebrand factor, C‑X‑C motif chemokine ligand 12 and tyrosine kinase with immunoglobulin‑like and EGF‑like domains 1. Therefore, it is hypothesized that tumor cells enhance the angiogenic properties of ECs, including proliferation, migration, invasion and tube formation in a tumor‑type‑dependent manner. This is likely based on the upregulation of pro‑angiogenic genes in ECs induced by varying cytokine secretion signatures of tumor cells.

Identifiants

pubmed: 31059104
doi: 10.3892/or.2019.7143
doi:

Substances chimiques

Culture Media, Conditioned 0
Platelet Endothelial Cell Adhesion Molecule-1 0
Vascular Endothelial Growth Factor A 0
Von Willebrand antigen 0
vascular endothelial growth factor A, rat 0
von Willebrand Factor 0
Fibroblast Growth Factor 2 103107-01-3

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

350-360

Auteurs

Majida Al-Abboodi (M)

Department of Plastic and Hand Surgery, Laboratory for Tissue Engineering and Regenerative Medicine, University Hospital of Erlangen, Friedrich‑Alexander University Erlangen‑Nürnberg (FAU), D‑91054 Erlangen, Germany.

Ran An (R)

Department of Plastic and Hand Surgery, Laboratory for Tissue Engineering and Regenerative Medicine, University Hospital of Erlangen, Friedrich‑Alexander University Erlangen‑Nürnberg (FAU), D‑91054 Erlangen, Germany.

Maximilian Weber (M)

Department of Plastic and Hand Surgery, Laboratory for Tissue Engineering and Regenerative Medicine, University Hospital of Erlangen, Friedrich‑Alexander University Erlangen‑Nürnberg (FAU), D‑91054 Erlangen, Germany.

Rafael Schmid (R)

Department of Plastic and Hand Surgery, Laboratory for Tissue Engineering and Regenerative Medicine, University Hospital of Erlangen, Friedrich‑Alexander University Erlangen‑Nürnberg (FAU), D‑91054 Erlangen, Germany.

Anne Klausing (A)

Department of Plastic and Hand Surgery, Laboratory for Tissue Engineering and Regenerative Medicine, University Hospital of Erlangen, Friedrich‑Alexander University Erlangen‑Nürnberg (FAU), D‑91054 Erlangen, Germany.

Raymund E Horch (RE)

Department of Plastic and Hand Surgery, Laboratory for Tissue Engineering and Regenerative Medicine, University Hospital of Erlangen, Friedrich‑Alexander University Erlangen‑Nürnberg (FAU), D‑91054 Erlangen, Germany.

Anja M Boos (AM)

Department of Plastic and Hand Surgery, Laboratory for Tissue Engineering and Regenerative Medicine, University Hospital of Erlangen, Friedrich‑Alexander University Erlangen‑Nürnberg (FAU), D‑91054 Erlangen, Germany.

Annika Kengelbach-Weigand (A)

Department of Plastic and Hand Surgery, Laboratory for Tissue Engineering and Regenerative Medicine, University Hospital of Erlangen, Friedrich‑Alexander University Erlangen‑Nürnberg (FAU), D‑91054 Erlangen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH